Affimed N.V. - Nilai perusahaan marang volume dodolan AFMD

Affimed automates the creation of cancer-fighting antibodies via AI platforms. The EV/Sales ratio demonstrates the market value of the business excluding debt, while the level captures the current state. A team of elite immunologists relies on a powerful foundation for innovation. However, success depends on clinical trials for lymphoma and the efficiency of capital management for R&D.
Affimed Therapeutics - rincian analitis lan metrik utama (AFMD)

The expansion dynamics of the ROCK platform within the immunopharmaceuticals segment are reflected in the revenue multiple of Affimed (AFMD), capturing the market's valuation of bispecific antibody potential. This indicator compares Enterprise Value to annual revenue, excluding the impact of debt load, which allows investors to assess the premium paid for future capitalization growth as clinical trials scale.